Ligand Pharmaceuticals Incorporated ( LGND) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Thank you for standing by. Welcome to Ligand Third Quarter 2025 Earnings Call. [Operator Instructions] I ...

Portfolio Receipts growth of 11% to $814 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $703 million Raised ...

Under the partnership between Alvotech and Advanz Pharma, Alvotech is responsible for the development and commercial supply of Gobivaz ®, while Advanz Pharma holds the registration and exclusive ...

In analyzing dozens of AI PoCs that sailed on through to full production use — or didn’t — six common pitfalls emerge.

Equinix is the most prominent colocation data center provider in the industry having developed the most widespread network of ...

Congolese traditional medicine is disappearing. Not due to a lack of usefulness, but due to a lack of space in an ...

Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the third quarter of 2025, as well as a quarterly cash dividend of $0.03 per ...

Secretin regulates Ca²⁺ signaling in interstitial cells of Cajal in the deep muscular plexus (ICC-DMP), revealing a targeted hormonal pathway that slows small intestinal transit to support nutrient ...

Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the third quarter of 2025, as ...